期刊文献+

PF方案新辅助化疗加局部放疗治疗T_4N_0M_0鼻咽癌近期疗效观察 被引量:1

Short-term efficacy of radiotherapy alone versus radiotherapy followed by new adjuvant chemotherapy in treatment of T_4N_0M_0 nasopharyngeal carcinoma
下载PDF
导出
摘要 目的比较单纯放疗与PF方案新辅助化疗+局部放疗T4N0M0鼻咽癌的临床疗效和毒副作用。方法64例T4N0M0鼻咽癌患者随机分为两组,32例行单纯放射治疗(单放组),32例接受PF(DDP+5-Fu)方案新辅助化疗,2个疗程后加放疗(PF组)。结果单放组和PF组在半量(36Gy)时鼻咽病灶有效率(PR+CR)分别为53.1%和68.7%(P>0.05);全量放疗结束时鼻咽病灶有效率(PR+CR)分别为81.2%和93.7%(P>0.05)。放疗毒副作用所致恶心、呕吐和骨髓抑制等差异均有显著性(P<0.05)。结论PF方案新辅助化疗加局部放疗治疗T4N0M0鼻咽癌较单纯放疗局控率较好,但前者毒副作用较重。 Objective To compare local control efficacy and toxicity of radiotherapy(RT) followed by new adjuvant chemotherapy(NC) versus radiotherapy alone in treatment of patients with T4N0M0 stage Ⅳ nasopharyngeal carcinoma(NPC). Methods From 2000 to 2004,62 stage T4N0M0 NPC patients were randomized into RT alone group and RT followed by NC group. The patients in the two groups were comparable in age,gender,stage and pathology. The NC group was treated with two courses of NC with DDP and 5-Fu before RT. Results The local control rates were 53. 1% for RT group and 68.7% for NC group at the dose of 36 Gy( P 〉 0.05 ). At the total dose, the local control rates were 81. 3% for RT group and 93.8% for NC group( P 〉 0.05 ). There was significant difference between the two groups in toxicity, such as nausea,vomiting and myelosuppression. Conclusion NC can significantly improve short-term efficacy and local control rates, but it has much toxicity.
出处 《中国肿瘤临床与康复》 2005年第6期551-552,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 鼻咽肿瘤/放射疗法 鼻咽肿瘤/化学疗法 Nasopharyngeal neoplasms/radiotherapy Nasopharyngeal carcinoma/chemotherapy
  • 相关文献

参考文献6

二级参考文献12

  • 1张恩罴,罗伟,钱剑扬,卢杰,钟宁山,毛志达,曾祥发,黄劭敏.改进鼻咽癌放射治疗技术的研究─—(Ⅰ)靶区剂量分布[J].癌症,1996,15(2):126-129. 被引量:55
  • 2[3]Forastiere AA, Neuberg D, Taylor SG, et al. Phase Ⅱ evaluation of taxol in advanced head and neck cancer: an eastern cooperative oncology group trial. J Natl Cancer Inst Monogr, 1993,15:181
  • 3[4]Tan EH, Khoo KS, Wee J, et al. Phase Ⅱtrial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma. Ann Oncol ,1999,10(2):235
  • 4[5]Yeo W, Leung TW, Chan AT, et al. A phase Ⅱ study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma. Eur J Cancer ,1998,34(13):2027
  • 5[1]Min H, Hong M, Ma J, et al. A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Biol Phys, 1994,30:1037
  • 6[2]Lee AM, Poon YF, Foo W, et al. Retrospective analysis of 5 037 patients with nasopharyngeal carcinoma treated during 1976~1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phtsy,1992, 23: 261
  • 7Chan A T,Int J Radiat Oncol Biol Phys,1995年,33卷,3期,569页
  • 8Zhang E P,Int J Radiat Oncol Biol Phys,1989年,16卷,2期,301页
  • 9魏宝清,中华放射肿瘤学杂志,1994年,3卷,3期,164页
  • 10魏宝清,中华放射肿瘤学杂志,1992年,1卷,1期,57页

共引文献113

同被引文献12

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部